| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA556: Darvadstrocel for treating complex perianal fistulas in Crohn's disease |
|
Medicine details |
|
| Medicine name | darvadstrocel (Alofisel®) |
| Formulation | 5 million cells/ml suspension for injection |
| Reference number | 1869 |
| Indication | Treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy. Alofisel should be used after conditioning of fistula |
| Company | TiGenix NV |
| BNF chapter | Gastro-intestinal system |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 07/11/2018 |
| NICE guidance | TA556: Darvadstrocel for treating complex perianal fistulas in Crohn's disease |